Hide filtersShow filters × Close Private Placement OncoImmunity AS Bryan, Garnier & Co acts as Co-manager on Canopy Growth’s benchmark CAD600 million Convertible Bond New Issue Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Voluntis’ IPO, the first ever listing of a digital therapeutics company raising EUR30.1 million Bryan, Garnier & Co acts as Lead Manager on Medigene’s EUR48.3 million offering Bryan, Garnier & Co advises ORPEA Group on the acquisition of Woonzorgnet B.V. in the Netherlands Bryan, Garnier & Co acts as Joint Global Coordinator on Celyad’s EUR46.1 million global equity offering Bryan, Garnier & Co acts as Sole Financial Advisor to Cyclopharma on its sale to Curium Pharma Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Medartis’ IPO CHF142.6 million on SIX Swiss Exchange Bryan, Garnier & Co part of bulge bracket syndicate for DBV $150 million Follow-on Bryan, Garnier & Co advises Bone Therapeutics on its €19.45 million convertible bond placement Bryan Garnier & Co acts as Global Coordinator for Biom’Up’s financing representing a total amount of more than €40 million Bryan, Garnier & Co advised Coltene in its acquisition of Kenda
